Posted Jul. 24, 2014 at 10:06 a.m.

Premium Lock GSK seeks regulator approval for malaria vaccine

Published: 2014-07-24 10:06:03
Updated: 2014-07-24 10:06:03

Fighting malaria Fighting malaria

The experimental shot is the most advanced candidate vaccine for malaria but results from previous trials have been disappointing. Research published in 2012 showed the shot only reduced malaria cases by about 30 percent in babies aged six to 12 weeks, the target age for immunization....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders